Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 0.41 |
| ▸ | KIF11 | P52732 | 3/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.39 |
| ▸ | CPA3 | P15088 | 1/20 | 0.39 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.39 |
| ▸ | SRC | P12931 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | MME | P08473 | 1/20 | 0.38 |
| ▸ | KCNN4 | O15554 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL856139 | 1.00 | CYP1A2 (0.41) | CYP1A2KIF11CYP2D6CPA3FOLH1 | |
| SCHEMBL335641 | 0.84 | KIF11 (0.52) | CYP1A2KIF11KMT2A | |
| SCHEMBL27713868 | 0.79 | LMNA (0.44) | CYP1A2KIF11CYP2D6SRCMAPT | |
| SCHEMBL9373145 | 0.78 | MAPT (0.45) | CYP1A2KIF11CYP2D6MAPTKMT2A | |
| SCHEMBL1235122 | 0.78 | KMT2A (0.48) | CYP1A2KIF11CYP2D6SRCMAPT | |
| SCHEMBL6505750 | 0.74 | CYP1A2 (0.39) | CYP1A2KIF11CYP2D6CPA3FOLH1 | |
| SCHEMBL4579475 | 0.73 | CYP1A2 (0.48) | CYP1A2KIF11CYP2D6SRCMAPT | |
| SCHEMBL29351710 | 0.73 | KIF11 (0.48) | CYP1A2KIF11CYP2D6MAPTKMT2A | |
| SCHEMBL34784 | 0.72 | FOLH1 (0.48) | CYP1A2KIF11CPA3FOLH1 | |
| SCHEMBL3785507 | 0.72 | FOLH1 (0.48) | CYP1A2KIF11CPA3FOLH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118006336-A | Construction and application of fluorescent lighting optical probe with high signal-to-noise ratio for detecting hypochlorite | 中国科学院新疆理化技术研究所 | 2024-05-10 | — | — | CN | claimed |
| US-9044519-B2 | Radiotracer precursor for imaging of hypoxic tissue, radiotracer, and method for preparing the same | Atomic Energy Council—Institute of Nuclear Energy Research (TW) | 2015-06-02 | — | — | US | claimed |
| US-9024035-B2 | Radiotracer precursor BANI for imaging of hypoxic tissue, radiotracer, and method for preparing the same | Atomic Energy Council—Institute of Nuclear Energy Research (TW) | 2015-05-05 | — | — | US | claimed |
| US-20150025248-A1 | RADIOTRACER PRECURSOR BANI FOR IMAGING OF HYPOXIC TISSUE, RADIOTRACER, AND METHOD FOR PREPARING THE SAME | ATOMIC ENERGY COUNCIL - INSTITUTE OF NUCLEAR ENERGY RESEARCH (TW) | 2015-01-22 | — | — | US | claimed |
| US-20140371434-A1 | RADIOTRACER PRECURSOR FOR IMAGING OF HYPOXIC TISSUE, RADIOTRACER, AND METHOD FOR PREPARING THE SAME | ATOMIC ENERGY COUNCIL-INSTTITUTE OF NUCLEAR ENERGY RESEARCH (TW) | 2014-12-18 | — | — | US | claimed |
| CN-118006336-A | Construction and application of fluorescent lighting optical probe with high signal-to-noise ratio for detecting hypochlorite | 中国科学院新疆理化技术研究所 | 2024-05-10 | — | — | CN | disclosed |
| CN-110885316-B | Sulfhydryl compound as histone deacetylase inhibitor and application thereof | 上海中泽医药科技有限公司 | 2023-03-28 | — | — | CN | disclosed |
| CN-114341158-A | Compounds comprising fibroblast activation protein ligands and uses thereof | 3B制药有限公司 | 2022-04-12 | — | — | CN | disclosed |
| CN-111943892-B | Histone deacetylase subtype inhibitor thioacetylarylamine compound and application thereof | 上海中泽医药科技有限公司 | 2022-04-05 | — | — | CN | disclosed |
| CN-111943892-A | Histone deacetylase subtype inhibitor thioacetylarylamine compound and application thereof | 上海中泽医药科技有限公司 | 2020-11-17 | — | — | CN | disclosed |
| CN-110885316-A | Sulfhydryl compound as histone deacetylase inhibitor and application thereof | 上海中泽医药科技有限公司 | 2020-03-17 | — | — | CN | disclosed |
| US-10259845-B2 | Peptides whose uptake by cells is controllable | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2019-04-16 | — | — | US | disclosed |
| US-7964752-B2 | Bifunctional compound containing amino group and diaminedithiol ligand and manufacturing method thereof | Atomic Energy Council—Institute of Nuclear Energy Research (TW) | 2011-06-21 | — | — | US | disclosed |
| US-20110040123-A1 | Bifunctional compound containing amino group and diaminedithiol ligand and manufacturing method thereof | ATOMIC ENERGY COUNCIL - INSTITUTE OF NUCLEAR ENERGY RESEARCH (TW) | 2011-02-17 | — | — | US | disclosed |
| EP-1996609-A2 | METHOD OF PREPARING GLYCOPEPTIDES | The Scripps Research Institute (US) | 2008-12-03 | — | — | EP | disclosed |
| EP-1896085-A1 | PEPTIDES WHOSE UPTAKE BY CELLS IS CONTROLLABLE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2008-03-12 | — | — | EP | disclosed |
| WO-2007111952-A2 | METHOD OF PREPARING GLYCOPEPTIDES | THE SCRIPPS RESEARCH INSTITUTE (US) | 2007-10-04 | — | — | WO | disclosed |
| US-20070041904-A1 | Peptides whose uptake by cells is controllable | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2007-02-22 | — | — | US | disclosed |
| WO-2006125134-A1 | PEPTIDES WHOSE UPTAKE BY CELLS IS CONTROLLABLE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2006-11-23 | — | — | WO | disclosed |
| US-20060041105-A1 | Peptides whose uptake by cells is controllable | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2006-02-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140371434-A1 | RADIOTRACER PRECURSOR FOR IMAGING OF HYPOXIC TISSUE, RADIOTRACER, AND METHOD FOR PREPARING THE SAME | HIF1A, HIF1AN, HYOU1 | CYP1A2 1190/4885KIF11 3931/4885CYP2D6 840/4885 |
| US-20070041904-A1 | Peptides whose uptake by cells is controllable | XPA, BMX, TPX2 | CYP1A2 4776/4885KIF11 3152/4885CYP2D6 4593/4885 |
| US-10259845-B2 | Peptides whose uptake by cells is controllable | XPA, BMX, TPX2 | CYP1A2 4776/4885KIF11 3152/4885CYP2D6 4593/4885 |
| US-20150025248-A1 | RADIOTRACER PRECURSOR BANI FOR IMAGING OF HYPOXIC TISSUE, RADIOTRACER, AND METHOD FOR PREPARING THE SAME | HIF1AN, HIF1A, PAICS | CYP1A2 1251/4885KIF11 4464/4885CYP2D6 1493/4885 |
| US-20110040123-A1 | Bifunctional compound containing amino group and diaminedithiol ligand and manufacturing method thereof | EPRS1, SLC7A5, ATIC | CYP1A2 3422/4885KIF11 3097/4885CYP2D6 3349/4885 |
| US-20060041105-A1 | Peptides whose uptake by cells is controllable | F13B, XPA, BMX | CYP1A2 4642/4885KIF11 2874/4885CYP2D6 3885/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.